We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Abaco Partners Gets Form 483 Due to Quality Control, Testing, Documentation and Training
Abaco Partners Gets Form 483 Due to Quality Control, Testing, Documentation and Training
Abaco Partners, operating as Surefil, has received a seven-observation Form 483 from the FDA after a November 2021 inspection of the company’s Grand Rapids, Mich., manufacturing facility turned up observations of testing and other quality lapses.